Pharmacy benefit managers, the drug industry middlemen who have been derided by everyone from community pharmacists to President Trump, have a new chief defender: longtime D.C. lobbyist JC Scott.

Scott, who most recently served as chief advocacy officer and head of external affairs at the medical device lobby, the Advanced Medical Technology Association, announced Thursday he will succeed Mark Merritt as the head of the PBM lobby, the Pharmaceutical Care Management Association, starting Oct 15.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Well of course they did! I wonder how many more American lives, this will cost. The device industry made sure that physicians, and hospitals could redact the names and registration records, form patient files, in order to hide the number of faulty devices, and protect the industry. This should be evidence of how corrupt the system is, instead it reads like public relations.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy